Nita Ahuja reports a stock award at Abbott Laboratories
By AlphaYouPublished Form 4
Ahuja Nita
Reporting filer
Nita Ahuja reports a stock award, not an open-market purchase or sale, in Abbott Laboratories. Form 4 filed Oct 2, 2026 lists 1 entry.
- Disclosed
- Oct 2, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Stock Equivalent Units (derivative) | Ahuja Nita | 2026-09-30 | A | Grant or award | 318 | 98.83 | 771 | 2 days | Filed terms
|
Stock Equivalent Units (derivative)
- Owner
- Ahuja Nita
- Date
- 2026-09-30
- Code
- A
- Action
- Grant or award
- Quantity
- 318
- Price
- 98.83
- Following holdings
- 771
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Stock Equivalent Units
- id: F1
- transaction Date: 2026-09-30
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 318
- transaction Price Per Share: 98.83
- transaction Acquired Disposed Code: A
- id: F1
- id: F1
- underlying Security Title: Common Shares
- underlying Security Shares: 318
- shares Owned Following Transaction: 771
- id: F2
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Ahuja Nita: Director.
- F1: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.
- F2: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.
Original sources
Prepared automatically from public filing data. Report a correction.